Mass General Brigham Cancer Institute 2026-2027: Archive
Massachusetts General Brigham
Cancer Center Grand Rounds 2026-2027
September 1, 2026 - June 30, 2027
Back again the 2026-2027 Cancer Center Grand Rounds are available to the public to attend virtually LIVE via paid subscription.
(Please note: This subscription does not include in-person attendance)
The theme of the series is “Avant Garde in Cancer Medicine”. The series will cover a comprehensive array of disease areas and topics, attendees will be provided with a robust selection of sessions to bring them up to speed on the most cutting-edge research and therapies in oncology.
The subscription will provide access to BOTH the live webinar AND the recording; however, if claiming credit, you may only claim credit for attending one or the other per date.
Course Directors:
Colin Weekes, MD, PhD, E.A. Chiocca, MD, PhD, Motaz Qadan, MD, PhD & Paul Nguyen, MD, PhD
Coordinator:
Bethyl Rose ([email protected])
For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at [email protected].
You may print individual certificates throughout the year; your cumulative list of sessions attended is accessible on your transcript.
Target Audience
This activity is intended for Physicians, Nurses, APPs, trainees with specialties of Oncology,
Learning Objectives
Upon completion of this activity, participants will be able to:
- To understand advances in the sequencing of treatment modalities in multidisciplinary cancer care
- To detail benefits and challenges of new technologies, drugs, and/or biologic agents in cancer care
- To promulgate innovative patient sample collection strategies to enable impactful correlative science
Additional Information
Mass General Brigham

Course summary
Sessions will be held weekly on Thursday from September 24, 2026 to June 30, 2027 from 12:00 to 1:00 PM.
| Date | Subject | Speaker |
|---|---|---|
September 24, 2026 | Of Mucins and Molecules: The Best-Laid Plans for MUC16-Directed Therapeutics and the Reality of Acquired Resistance | Oladapo Yeku, MD |
October 1, 2026 | Cancer Immunotherapy Based on Nucleic Acid Self-nonself Discrimination | Arthur Kreig, MD |
October 22, 2026 | ASCO Updates | ASCO Updates |
Colin Weekes, MD, PhD
Director, Medical Oncology Research for Pancreatic Cancer,
Director, Cancer Center Grand Rounds Program
Massachusetts General Hospital
E. Antonio Chiocca, MD, PHD
Vice President
American Association of Neurological Surgery,
Massachusetts General Hospital
Motaz Qadan, MD, PhD
Associate Professor of Surgery,
PCE Core Faculty in the Surgery Core Clerkship
Harvard Medical School
Associate Visiting Surgeon
Surgical Oncology,
Massachusetts General Hospital
Paul Nguyen, MD, PhD
Professor
Harvard Medical School;
Executive Vice-Chair of Radiation Oncology
Brigham and Women's Hospital;
Director of Genitourinary Radiation Oncology,
Dana-Farber Cancer Institute
DISCLOSURE SUMMARY OF RELEVANT FINANCIAL RELATIONSHIPS
MITIGATION STRATEGIES
Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public. All reviewers have no relevant relationships with ineligible companies.
DISCLOSURE SUMMARY OF RELEVANT FINANCIAL RELATIONSHIPS
MITIGATION STRATEGIES
Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public. All reviewers have no relevant relationships with ineligible companies.
The following planners have reported no relevant financial relationship with an ineligible company:
Kellyanne Jeffries, CNP
E. Antonio Chiocca, MD, PhD
Gerard Doherty, MD
Paul Nguyen, MD, MBA
The following planners have reported relevant financial relationships with an ineligible company:
Colin Weekes, MD, PhD
Consultant: BMS, Novartis, Ipsen
Researcher: Novartis, Ipsen, Elicit, Dicephera
ACCREDITATION

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditTM
Mass General Brigham designates this enduring activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Mass General Brigham designates this activity for 1 ANCC contact hour. Nurses should only claim credit commensurate with the extent of their participation in the activity.

Facebook
X
LinkedIn
Forward